6月 2026
gnhindia.com
顯示 Similarweb 的估計資料。
透過連接你的 GA4 公開驗證你網站的指標
反映您的成功
連接 Google Analytics,認證您網站的流量和參與度指標
跳出率
40.9%
每次訪問頁數
1.98
平均訪問時長
00:00:31
- 公司介紹
- - -
- 行業
- - -
gnhindia.com 的前十大競爭對手
在 6月 2026,系統根據關鍵字流量、受眾定位與市場重疊率與 gnhindia.com 的相似程度,排名出 gnhindia.com 等前 10 名網站。
Amodex's ink stain remover tackles tough ink stains with ease. Lab-tested, fabric-safe, and expert-recommended. Shop now.
- 公司介紹
- - -
- 行業
- - -
跳出率
28.11%
每次訪問頁數
3.36
平均訪問時長
00:05:19
相似度評分
100%Discover Healing Pharma’s range of hair care, skin care & nutrition supplements. Safe, affordable & effective wellness solutions for everyday health.
- 公司介紹
- - -
- 行業
- - -
跳出率
50.37%
每次訪問頁數
1.80
平均訪問時長
00:00:53
discover jublia® (efinaconazole), an fda-approved prescription topical solution for toenail fungus (onychomycosis).
跳出率
55.44%
每次訪問頁數
1.55
平均訪問時長
00:01:52
相似度評分
81%IPN, New Delhi can facilitate patient to "import of Medicines For Leukemia Treatment" for personal use under "patient name basis" treatment in India.
跳出率
64.02%
每次訪問頁數
1.33
平均訪問時長
00:00:14
Africa faces up to 500K deaths yearly from fake/substandard drugs (18-42% prevalence), causing treatment failures & resistance. Indian NGOs boost local mfg & quality supply to ensure safe meds.
- 公司介紹
- Impact Care
- 行業
- N/A
跳出率
62.62%
每次訪問頁數
1.20
平均訪問時長
00:00:02
See Important Safety Information, including Boxed Warning on addiction, abuse, and misuse and other serious risks. A site map for NUCYNTA and NUCYNTA ER.
- 公司介紹
- - -
- 行業
- - -
跳出率
49.44%
每次訪問頁數
1.84
平均訪問時長
00:00:23
相似度評分
69%Remedive is a healthcare platform to enable customers to avail healthcare and medicines in a hassle free convenient way. Remedive brings you your daily/ monthly medicines at your doorsteps as well as gives you the opportunity to set appointments with doctors.
- 公司介紹
- - -
- 行業
- - -
全球排名
#1,592,083
1,180,762國家/地區排名
#16,269
10,234同類排名
- -
跳出率
39.82%
每次訪問頁數
1.73
平均訪問時長
00:00:34
相似度評分
62%Managing type 2 diabetes effectively requires a combination of the right medication, lifestyle changes, and continuous monitoring. GLIDAPA TENMET 500, a powerful triple-combination tablet containing Dapagliflozin (10 mg), Teneligliptin (20 mg), and Metformin Hydrochloride (500 mg), is designed to provide comprehensive glycemic control for individuals suffering from type 2 diabetes mellitus. This advanced formulation works through multiple mechanisms to regulate blood sugar levels, improve insulin sensitivity, and reduce glucose production, making it an ideal solution for patients who require combination therapy. How GLIDAPA TENMET 500 Works GLIDAPA TENMET 500 combines three well-established antidiabetic agents, each targeting different pathways: Dapagliflozin works by inhibiting SGLT2 receptors in the kidneys, promoting the excretion of excess glucose through urine. Teneligliptin increases incretin hormone levels, which stimulate insulin secretion and decrease glucagon release after meals. Metformin Hydrochloride reduces hepatic glucose production and improves insulin sensitivity in peripheral tissues. Together, this triple-action formula ensures better blood sugar control throughout the day, especially for patients with uncontrolled diabetes on monotherapy. Uses of GLIDAPA TENMET 500 GLIDAPA TENMET 500 is primarily prescribed for: Management of Type 2 Diabetes Mellitus Patients with inadequate glycemic control on dual therapy Reducing fasting and postprandial blood glucose levels Improving insulin sensitivity Supporting weight management in diabetic patients It is usually recommended along with a proper diet and regular exercise for optimal results. Key Benefits of GLIDAPA TENMET 500 1. Triple Mechanism Action Unlike single or dual therapy drugs, this combination provides a three-way approach to diabetes control, targeting different physiological processes. 2. Effective Blood Sugar Control It helps maintain stable glucose levels throughout the day, red
- 公司介紹
- - -
- 行業
- - -
跳出率
28.56%
每次訪問頁數
1.79
平均訪問時長
00:03:02
光成薬品株式会社のお問い合わせページです。1952年創業の医薬品卸会社です。日本全国の病院、開業医、調剤薬局、薬店等に医薬品の販売・買取を行っています。
跳出率
81.65%
每次訪問頁數
1.11
平均訪問時長
00:00:02
イワキ株式会社は、アステナグループの一員として化粧品原料,機能性食品原料,健康食品原料,医療機器,バイオ関連製品を扱っています。
- 公司介紹
- Iwaki kk
跳出率
16.65%
每次訪問頁數
3.87
平均訪問時長
00:05:29
gnhindia.com 在 6月 2026的前 5 大競爭對手是:amodexusa.com、healingpharmaonline.com、jubliarx.com、indianpharmanetwork.co.in 等。
根據 Similarweb 月造訪量數據,gnhindia.com 在 6月 2026 的主要競爭對手為 amodexusa.com。與 gnhindia.com 相似度排名第二的網站是 healingpharmaonline.com,緊隨其後位居前三的是 jubliarx.com。
在 6月 2026,indianpharmanetwork.co.in 被評為與 gnhindia.com 相似度第四高的網站,impactcare.co.in 則位居第五。
前十名榜單中的其他五家競爭對手分別是 nucynta.com、remedive.com、sterisindia.com、koseipharma.com 和 iwaki-kk.co.jp。
